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The present study aimed to investigate the effects of daily (45 days) intake of ﬁsh oil (FO; 10 mg EPA/kg
body weight (BW) and 7 mg DHA/kg BW) and/or natural ASTA (1 mg ASTA/kg BW) on oxidative stress and
functional indexes of neutrophils isolated from Wistar rats by monitoring superoxide (O2 ), hydrogen
peroxide (H2O2), and nitric oxide (NO
) production compared to the progression of auto-induced lipid
peroxidation and Ca2+ release in activated neutrophils. Furthermore, phagocytic capacity, antioxidant
enzyme activities, glutathione-recycling system, and biomarkers of lipid and protein oxidation in neutro-
phils were compared to the redox status. Our results show evidence of the beneﬁcial effects of FO + ASTA
supplementation for immune competence based on the redox balance in plasma (signiﬁcant increase in
GSH-dependent reducing power), non-activated neutrophils (increased activity of the glutathione-recy-
cling enzymes GPx and GR) and PMA-activated neutrophils (lower O2 , H2O2, and NO
 generation, reduced
membrane oxidation, but higher phagocytic activity). Combined application of ASTA and FO promoted
hypolipidemic/hypocholesterolemic effects in plasma and resulted in increased phagocytic activity of
activated neutrophils when compared with ASTA or FO applied alone. In PMA-activated neutrophils,
ASTA was superior to FO in exerting antioxidant effects. The bulk of data reinforces the hypothesis that
habitual consumption of marine ﬁsh (e.g. salmon, which is a natural source of both astaxanthin and ﬁsh
oil) is beneﬁcial to human health, in particular by improving immune response and lowering the risk of
vascular and infectious diseases.
 2012 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
Habitual intake of marine ﬁsh and seafood has been strongly
associated with human health. It is particularly considered to
enhance immune competence and prevent infectious diseases
[1]. Fish oil (FO) components eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) – well-known as n-3 polyunsaturated
fatty acids (n-3/PUFA) – have been studied in immune cells and
proved to increase anti-inﬂammatory responses by stimulating
interleukin production [2]. As central players in inﬂammatory pro-
cesses, neutrophils are main protagonists of innate immune re-
sponses necessary for early host defense [3]. Regarding
nutraceuticals, dietary long-chain (>C20) n-3/PUFAs are considered
antioxidant compounds, which signiﬁcantly diminish superoxide
(O2 ) and hydrogen peroxide (H2O2) production in activated
neutrophils [4,5]. On the other hand, ﬁsh oil also showed adverse.
.br (R. Otton).
er the Elsevier OA license.effects on immune function due to the inﬂuence of PUFAs on mem-
brane ﬂuidity, which could result in higher sensitivity to oxidation
[6,7]. Depending on the concentration, DHA and EPA can also affect
the microstructure and composition of lipid rafts in the neutrophil
membrane, resulting in severe changes of cell–cell molecular com-
munication [8].
Although anti-inﬂammatory mechanisms in humans have been
well discussed, there are still unanswered questions with respect to
redox imbalances provoked in neutrophils during the pathogen-
activation process. As a consensus, a wide range of reactive oxy-
gen/nitrogen species ROS/RNS (including O2 , H2O2, and NO
) are
continuously produced by neutrophil oxidative burst, and pathogen
cells are undoubtedly not the only targets at the inﬂammatory site.
In fact, ROS/RNS can also (auto)-oxidize neutrophil membrane, trig-
gering lipid peroxidation and producing lipid-derived cytotoxic
aldehydes, e.g. malondialdehyde and 4-hydroxynonenal [9]. Thus,
long-living/persistent neutrophils as part of an efﬁcient immune
system have to cope with huge oxidative challenges imposed by
pathogen activation. Several authors have, therefore, proposed that
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fer enhancement of immune functions, especially in terms of life-
span and slower turnover of damaged immune cells [10,11].
Accordingly, many antioxidants present in human diet have also
positively affected immune functions in patients of ROS-related dis-
eases, such as diabetes [12,13].
The marine carotenoid astaxanthin (ASTA; Fig. 1) is naturally
found in a wide variety of aquatic organisms, such as microalgae,
crustaceans (crabs, lobsters, and shrimp), and ﬁshes (salmon and
trout). ASTA is renowned as a powerful antioxidant [14,15], and
also reported to afford beneﬁts to human health, including photo-
protection against UV radiation (skin and eyes) [16], prophylaxis/
remediation of gastric ulcer induced by Helicobacter pylori [17],
and ROS-mediated neurodegenerative processes, as in Parkinson’s
disease [18]. Thus, it is reasonable to assume that combined FO
and ASTA supplementation could better balance pro- and antioxi-
dative events in activated neutrophils to enhance anti-inﬂamma-
tory responses and, thus, provide substantial health beneﬁts to
humans.
The present study aimed to investigate the effects of daily in-
take of natural sources of n-3/PUFAs (here provided as ﬁsh oil)
and/or natural ASTA (obtained from the biomass of the green mic-
roalgae Haematococcus pluvialis) [19] on oxidative stress and func-
tional indexes of neutrophils isolated from Wistar rats. This study
was performed by monitoring superoxide (O2 ), hydrogen peroxide
(H2O2), and nitric oxide (NO) production compared to the progres-
sion of auto-induced lipid peroxidation and Ca2+ release in acti-
vated neutrophils. Furthermore, our study evaluated antioxidant
enzyme activities, the glutathione-recycling system and biomark-
ers of lipid and protein oxidation as related to the FO and/or ASTA
diet, and examined the redox status in plasma as well as in isolated
resting and stimulated neutrophils from experimental animals.
2. Materials and methods
2.1. Chemicals
All chemicals were of analytical grade and purchased from Sig-
ma–Aldrich Chemical Company (St. Louis, MO, USA), except those
used in the preparation of common buffers (Labsynth, Diadema,
SP, Brazil). Commercial biochemical test kits were obtained from
Bioclin-Quibasa Química Básica (Belo Horizonte, Brazil) for mea-
surements of glucose (prod. code K082), triacylglycerol (prod. code
K055) and cholesterol (prod. code k083) concentrations in plasma.
The ﬂuorescent probes acetoxymethyl ester (Fura 2-AM) and 4,
4-diﬂuoro-5-(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-s-inda
cene-3-undecanoic acid (C11-BODIPY581/591) were purchased from
Invitrogen (Grand Island, NY, USA).
2.2. Natural products
Fish oil capsules were purchased from Pharmanostra (Sao Paulo,
SP, Brazil). Each ﬁsh oil (FO) capsule of 500 lL (corresponding to
9 kcal/38 kJ), contains 2.0 mg tocopherols, and 1.0 g of total fat,
out of 30% which saturated fats, 20% with monounsaturatedCH3
CH3 CH3
H3C CH3 CH3 CH3
H3C
H3C CH3
O
O
HO
OH
Fig. 1. Chemical structure of the marine carotenoid astaxanthin (ASTA).(mostly palmitoleic and oleic acids), and 50% with polyunsaturated
fatty acids (180 mg EPA and 120 mg DHA). Natural ASTA supple-
ments (AstaREAL A1010) were obtained as a donation from the
Swedish company BioReal AB (Gustavsberg, Sweden), a subsidiary
of BioReal Inc., (Hawaii, USA) and part of the pharmaceutical Group
Fuji Chemical Industry CO. AstaREAL A1010 is an astaxanthin-rich
natural microalgal product, consisting of crushed and spray-dried
aplanospores of the green microalgae Haematococcus pluvialis.
AstaREAL A1010 contains 42% of crude fat, 10% of crude protein,
40% of carbohydrates, and 4% of ashes. Regarding carotenoid com-
position, AstaREAL A1010 contains 5.2–5.8% of total carotenoids,
5.0–5.6% of which are being pure astaxanthin (3.9% as monoesters,
0.9% as diesters, and 0.1% in free form) among others.
2.3. Animals and supplementation protocols
Adult Wistar male rats, weighing 191 ± 35 g at the beginning of
the study, were provided by the Department of Psychobiology, Uni-
versidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. All ani-
mals were housed in plexiglas cage (four rats/cage), under
standard laboratory conditions: 12 h light/dark cycle; lights on at
7:00 a.m.; 22 ± 1 C; water and Purina rat chow ad libitum. The ani-
mals used in this study were handled in accordance with the
guidelines of the committee on care and use of laboratory animal
resources of the Ethics Committee on Care and Use of Laboratory
Animal Resources from Universidade Federal de Sao Paulo, which
approved the study protocol (CEP/UNIFESP n 1938/09). The ani-
mals were treated with ASTA and/or FO by gavage, 5 days a week,
for 45 days. A maximum volume of 400 lL was established for the
gavage treatment in order to prevent regurgitation or stomach dis-
comfort of the animals. Fish oil (FO) content of capsules was di-
luted in 10% Tween 80 aqueous solution (v/v) to reach ﬁnal n-3/
PUFAs concentrations of 10 mg EPA/kg body weight (BW) and
7 mg DHA/kg BW. An identical procedure was conducted for ani-
mal supplementation with 1 mg ASTA/kg BW using AstaREAL
A1010 as the carotenoid source (5.3% of which is pure ASTA). For
combined FO and ASTA treatments, both components were diluted
in the same stock 10% Tween-80 aqueous solution (v/v) to reach
previously described concentrations. Although additional antioxi-
dants as ascorbate, tocopherols and other carotenoids were present
in both manufactured natural products, their contribution in the
total antioxidant capacity of gavage solutions is minor compared
to the prevalent ASTA or n-3/PUFA components. Thus, four exper-
imental groups of 16 animals each were formed: (i) control, fed
with 400 lL of 10% Tween 80 aqueous solution (v/v); (ii) ASTA,
fed with 1 mg ASTA/kg; (iii) FO, fed with 10 mg EPA/kg and 7 mg
DHA/kg; and (iv) ASTA + FO, fed with 1 mg ASTA/kg, 10 mg EPA/
kg and 7 mg DHA/kg.
2.4. Neutrophil isolation
After 45 days of treatment, the rats were euthanized by decapi-
tation between 11:00 a.m. and 01:00 p.m. to prevent circadian dif-
ferences. Prior to decapitation (4 h), rats were intraperitoneally
(i.p.) injected with 10 mL 1% (w/v) glycogen solution (Sigma type
II, from oyster) in PBS to induce cell migration. Neutrophils were
obtained by i.p. lavage with 20 mL PBS, followed by centrifugation
in a density gradient of Histopaque 1077 [20]. The total number
of leukocytes in exudate was determined in a haemocytometer.
The differential cell count was obtained by optical microscopy
(100) (Nikon YS2-H) of a cytospin cell layer stained with Giemsa.
The staining allowed the identiﬁcation of about 98% of neutrophils
present in the exudate 4 h after injection of oyster glycogen.
Neutrophils (1  106 cell/mL) were resuspended in RPMI-1640
medium supplemented with 10% foetal calf serum, 20 mM HEPES,
2 mM glutamine, and antibiotics (streptomycin 100 U/mL and
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phagocytic activity, ROS/RNS production, calcium release and
membrane oxidation. All other experiments were performed with
cells after they were frozen at 80 C.
2.5. Phagocytic activity
Neutrophils (1  106 cell/mL) were incubated for 60 min at
37 C in 1 mL RPMI 1640 medium with zymosan. Particles were
opsonized by incubation in the presence of control serum for
60 min at 37 C. Cells were incubated with particles and counted
after cytocentrifugation. Scores of phagocytosis were expressed
by the number of cells that had one, two, three, four, or more
zymosan particles phagocyted [21].
2.6. Analyses in plasma
2.6.1. Plasma preparation
Brieﬂy, total blood volume (5 mL) was collected in EDTA-Vac-
utainer tubes (5.4 mg K2EDTA spray-dried, cod. 367835) and
centrifuged for 10 min, 300g at room temperature. The clean plas-
ma fraction was then removed and stocked in Eppendorf 2 mL-
microtubes at 80 C for further analyses.
2.6.2. Glucose, triacylglycerol and cholesterol determinations in
plasma
Glucose, triacylglycerol (TAG), and cholesterol levels in plasma
were all quantiﬁed by commercial test kits obtained from
Bioclin-Quibasa Química Básica (Belo Horizonte, Brazil). All these
assays were based on the peroxidase-catalysed oxidation of 4-ami-
noantipyrine by hydrogen peroxide (H2O2) to generate a pink color
[22,23].
2.6.3. Glutathione redox status in plasma
Reduced glutathione content in plasma (GSH) was measured as
described by Rahman et al. [24]. The method is based on the reac-
tion of reduced thiol groups (such as in GSH) with 5,50-dithiobis-2-
nitrobenzoic acid (DTNB) to form 5-thio-2-nitrobenzoic acid (TNB),
which is stoichiometrically detected by absorbance at 412 nm.
Puriﬁed GSH and GSSG were used as standards. The Reducing
Power index reveals the ratio between GSH and GSSG – thus, the
reducing capacity of a biological system – and is calculated by
the equation (Eq. (1)):
Reducing Power ¼ ½GSH=ð½GSH þ 2½GSSGÞ ð1Þ2.6.4. Lipid oxidation in plasma
The extent of lipid peroxidation in plasma was determined as
the concentration of thiobarbituric acid-reactive substances
(TBARS) [25]. Butylated hydroxytoluene (4% BHT, in ethanol) was
added to stop progressing oxidation reactions in 500 lL diluted
samples. For the detection of the colored adducts, 500 lL of each
sample was incubated at 100 C for 15 min with 0.375% thiobarbi-
turic acid in 0.25 M HCl and 1% Triton X-100. After reaching room
temperature, absorbance of the reaction system was measured at
535 nm (blanks lack thiobarbituric acid) using malondialdehyde
(MDA) as a standard.
2.7. Biochemical measurements in neutrophils
2.7.1. Superoxide radical (O2 ) production
The lipophilic and freely diffusible probe dihydroethidium
(DHE) was used for the ﬂuorimetric measurement of intracellular
production of O2 [26]. Once inside cells, DHE is rapidly oxidized
to ethidium (a red ﬂuorescent compound) by O2 and H2O2 (in
the presence of peroxidase). Ethidium is trapped in the nucleusby intercalating into DNA, leading to an increase of ethidium ﬂuo-
rescence. The cells (5  105/well) were preloaded with 5 lM DHE
for 15 min at room temperature in the dark. The assay was carried
out in the presence and the absence of 20 ng/well phorbol myris-
tate acetate (20 ng PMA/well), here applied as a chemical inducer
of ROS production in neutrophils. Fluorescence was measured at
396 nm of excitation wavelength and at 590 nm of emission wave-
length in a microplate ﬂuorescence analyzer (Tecan, Salzburg,
Austria).2.7.2. Hydrogen peroxide production
The total production of H2O2 was evaluated before/after chem-
ical stimulation (with 20 ng PMA) of a 5  105 cell/well suspension
using the horseradish peroxidase-dependent oxidation of phenol
red (by H2O2) to form a vivid red color, which was spectrophoto-
metrically quantiﬁed at 620 nm, using a H2O2 concentration curve
as a standard [27].2.7.3. Nitric oxide production
Nitric oxide production was determined by spectrophotometric
analysis of total nitrite, using Griess reagent (1% sulfanilic acid,
0.1% N-(1-naphthyl)ethylenediamine hydrochloride), according to
Ding et al. [28]. Supernatant of neutrophils (5  105 cell/well) with
or without lipopolysaccharide (LPS-10 l/mL) was added to 100 lL
of Griess reagent, the absorbance measured in 550 nm, and nitrite
levels determined by means of a standard curve generated using
NaNO2.2.7.4. Intracellular Ca2+ concentration
Intracellular changes of calcium levels (Ca2+) were monitored in
neutrophils using the calcium-sensitive ﬂuorescent probe Fura 2-
AM. The 1  106 neutrophil suspension was pre-loaded with
5 lM Fura 2-AM for 1 h at 37 C in Tyrode’s solution. Afterwards,
neutrophils were washed and intracellular Ca2+ release was moni-
tored for 60 min at a wavelength emission of 510 nm (excitation
wavelengths alternating between 340 and 380 nm) in a microplate
reader (Tecan, Salzburg, Austria). Transformation of the ﬂuores-
cence signal to Ca2+ concentration was performed by calibration
with ionomycin (100 lM, maximum concentration) and EGTA
(60 lM, minimum concentration) according to the Grynkiewicz
equation and Kdiss of 224 nM [29].2.7.5. Membrane oxidation
The progression of membrane oxidation in PMA-activated neu-
trophils was monitored by ﬂuorescence kinetics of the C11-BODI-
PY581/591 probe, which is oxidized by alkoxyl and peroxyl radicals
(strongly involved in lipid peroxidation progress) and loses thereby
ﬂuorescence emission in the red region [30]. Brieﬂy, 5  105 neu-
trophils were pre-incubated with 3.2 lM C11-BODIPY581/591 for
60 min at room temperature, under mechanical agitation and in
the dark. The C11-BODIPY581/591-loaded neutrophils were placed
in a microplate, and background ﬂuorescence was adjusted to 1.0
relative ﬂuorescence unit (RFU) and measured for 10 min (kexcita-
tion = 545 nm, kemission = 591 nm) in a microplate reader (Tecan,
Salzburg, Austria). Afterwards, 100 ng PMA/5  105 cells were
added to trigger ROS production and start auto-induced membrane
oxidation, which was followed for additional 15 min. A ﬁrst-order
exponential decay function (Eq. (2)) was applied to obtain kinetic
parameters of lipid peroxidation in the neutrophil membrane.
yðRFUÞ ¼ y0 þ A1eðt=kÞ1 ð2Þ
RFU = relative ﬂuorescence unit; y0 = initial calculated relative ﬂuo-
rescence unit; A1 = intensity factor; t = time (s); k1 = rate constant.
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Neutrophils (5  106/mL) were isolated and ruptured by ultra-
sonication in a Vibra Cell apparatus (Connecticut, USA) in an
ice-water bath using 500 lL of each assay-speciﬁc extraction solu-
tion/buffer. Afterwards, ruptured neutrophils were centrifuged for
10 min, 10.000g at 4 C, and the supernatant was removed and
kept on ice for further analysis (debris was discarded).
2.7.7. Assay of superoxide dismutase activity (SOD)
The activity of total superoxide dismutase (SOD) was measured
according to Ewing & Janero [31], with modiﬁcations. The reaction
system for total SOD determination included 50 mM sodium phos-
phate buffer (pH 7.4), 0.1 mM EDTA, 50 lM nitroblue tetrazolium
(NBT), 78 lM NADH, and 3.3 lM phenazine methosulphate (PMS),
here used as a chemical O2 source. Analysis of mitochondrial (man-
ganese-dependent) MnSOD activity was performed similarly as for
total/SOD, but under strong inhibition (88–100%) of the cytosolic
CuZnSOD isoform by addition of 3 lM KCN. As internal controls of
the experiment, all reagents without sample were used for both
totalSOD and MnSOD determination. Absorbance at 550 nm was
continuously monitored for over 2 min in order to evaluate O2 -
mediated reduction of NBT. One SOD unit is deﬁned here as the
enzyme concentration required for 50% inhibition of NBT reduction
at 25 C.
2.7.8. Assay of catalase activity
The decomposition of H2O2 was directly followed for 2 min by
measuring the decrease in absorbance at 240 nm using a molar
extinction of e240 = (0.0394 ± 0.0002) LmM1cm1, as described
by Aebi [32]. One catalase (CAT) unit is deﬁned as the enzyme con-
centration required for the decomposition of 1 lmol of H2O2 per
min at 25 C. As internal control, 50 mM (pH 7.4) phosphate buffer
was added to H2O2 without sample and monitored for 2 min.
2.7.9. Assay of the glutathione-recycling enzyme system
The activity of glutathione peroxidase (GPx) was measured
according to Mannervik [33] using 2.5 U/mL glutathione reductase
(GR), 10 mM reduced glutathione (GSH), 250 lM sodium azide (as
a catalase inhibitor), and 1.2 mM NADPH. The reaction was trig-
gered by addition of 4.8 mM tert-butyl hydroperoxide (a GPx sub-
strate). The other GSH-recycling component enzyme, glutathione
reductase (GR), was, in turn, measured by a direct reaction be-
tween 3.6 mM NADPH and 10 mM oxidized glutathione (GSSG).
Absorbance of NADPH oxidation (in 0.2 M phosphate buffer, pH
7.4) was monitored in both cases at 340 nm for 2 min in an Ultro-
spec 3000 spectrophotometer (Pharmacia Biotech).
2.7.10. Oxidative stress parameters
Carbonyl groups were evaluated as parameters of amino acid
oxidation in neutrophils. After pre-treatment with 10% streptomy-
cin to remove interfering nucleic acids, the protein fractionwas iso-
lated from homogenate by precipitation with 20% trichloroacetic
acid solution on ice, followed by the subsequent processes: (i)
washing once with 0.3 M HClO4, 5 mM EDTA, and 0.06% 2,20-bipyr-
idine solution; (ii) washing twice with the mixture 1:1 ethyl ace-
tate:ethanol (v/v); and (iii) removing residual organic solvent in
vacuum for, at least, 30 min. Afterwards, the protein pellets were
fully dissolved in 6 M guanidine hydrochloride and used for detec-
tion of the carbonyl groups after reaction with 10 mM dinitrophen-
ylhydrazine (DNPH) in 0.25 M HCl (blanks lack DNPH). Absorbance
was recorded at 380 nm, and the carbonyl group concentration was
calculated using an extinction coefﬁcient of k = 2.2  104 M1 cm1
[34]. Reduced and oxidized glutathione (GSH and GSSG, respec-
tively) and TBARS (biomarker of lipid oxidation) were also
measured in homogenates of neutrophils, following the same
procedures as described for plasma samples.2.8. Statistical analyses
All data are presented as the mean values of, at least, triplicates
with their standard errors (MEAN ± SE). Data were analyzed by one-
way ANOVA followed by Tukey’s post-test, considering p < 0.05,
p < 0.01, or p < 0.005. The software Origin 6.1 (v6.1052/B232; Orig-
inLab Corporation, Northampton, MA, USA) was used for statistical
analyses and graph preparation.3. Results
3.1. Plasma indexes
All the experimental groups showed similar growth rates (BW)
during the 45-day supplementation period (data not shown),
although ASTA supplementation alone distinctively increased lipi-
demia (55%) and cholesterolemia (35%, compared to control; Table
1). This effect was not observed in animals from the FO + ASTA
group. Regarding redox balance, combined FO + ASTA clearly en-
hanced the antioxidant capacity of plasma, especially when com-
paring GSH/GSSG ratios (6-fold higher). Basal NO concentration
in plasma was also increased in FO + ASTA animals (65%, Table
1), whereas no signiﬁcant difference was observed in terms of lipid
oxidation.
3.2. Non-stimulated neutrophils
The redox balance was also studied in neutrophils isolated from
the experimental animals, as shown in Table 2. Concerning the
frontline antioxidant enzymes (Table 2), ASTA alone provided the
most signiﬁcant effects, especially on the GSH-recycling enzymes
GPx and GR (increased by 92% and 52%, respectively). However,
GSH content and GSH-related Reducing Power (see Section 2) were
abruptly depleted in neutrophils of ASTA-fed animals (both by
approximately 70%; Table 2). FO treatment caused a different effect
on neutrophils, since massive decreases in GPx (50%) and GR activ-
ities (65%) were accompanied by proportionally augmented levels
of GSH (80%) and Reducing Power (89%). Combined FO + ASTA sup-
plementation resulted in increased activities of total SOD (20%),
mitochondrial MnSOD (22%), GPx (62%), and GR (36%). Unexpect-
edly, all supplementation treatments resulted in lower activities
of CAT: 35% in ASTA group, and 45% in both FO and FO + ASTA ani-
mals (compared to control). Despite all changes observed in GSH
content, none of the experimental groups showed statistically dif-
ferent indexes of oxidative modiﬁcation in lipids (TBARS content)
or proteins (carbonyls) compared to control neutrophils, except
protein carbonyls of ASTA-fed animals (33% higher than control).
3.3. Activated neutrophils
In order to evaluate one of the most important neutrophil-func-
tional parameters, after 45-day of treatment with FO and/or ASTA,
neutrophils were challenged in vitro with opsonized zymosan par-
ticles (phagocytic capacity). The effect of ASTA and/or FO supple-
mentation on neutrophil was also evaluated by measuring ROS/
RNS production and auto-induced lipid peroxidation after chemical
(PMA-) activation of neutrophils. As shown in Fig. 2, the phagocytic
capacity of neutrophils was especially improved by FO supplemen-
tation (approximately 2.4-fold higher), whereas ASTA only
displayed marginal effects (not signiﬁcant, compared to control;
p = 0.180).
In order to investigate whether FO and/ASTA can exert effects on
O2 production, freshly isolated neutrophils were incubated with
DHE for 15 min. All supplementation protocols resulted in higher
basal O2 production in non-stimulated neutrophils. This effect
Table 1
Plasma levels of physiological and oxidative stress biomarkers of Wistar rats supplemented with 1 mg/kg/BW ASTA and/or FO (equivalent to 10 mg EPA/kg and 7 mg DHA/kg) for
45 days (5 days/week).
Control ASTA FO FO + ASTA
Glucose 156.1 (±20.7) 163.1 (±5.6) #FOA 173.7 (±47.9) 144.6 (±6.5) #A
Triacylglycerol 106.4 (±2.9) 164.3 (±27.2) §C, FOA #FO 92.6 (±13.3) #A 106.7 (±13.0) §A
Cholesterol 74.9 (±4.1) 100.8 (±12.7) *C, FO 72.5 (±10.1) *A 78.7 (±16.3)
GSH 0.081 (±0.041) 0.108 (±0.058) *FOA 0.110 (±0.046) *FOA 0.158 (±0.056) #C, *A, FO
GSSG 0.097(±0.026) 0.093 (±0.029) #FOA 0.087 (±0.028) #FOA 0.029 (±0.006) #A, FO
Reducing power 0.294(±0.169) 0.367 (±0.228) 0.387 (±0.204) 0.731 (±0.300) *C, A, FO
Nitric oxide 6.68(±2.17) 6.57 (±1.44) #FOA 8.88 (±1.63) 11.12 (±1.01) *C, #A
TBARS 1.34 (±0.31) 0.85 (±0.39) 1.36 (±0.52) 1.11 (±0.38)
Related to C (Control), A (ASTA), FO (Fish oil), FOA (Fish oil + ASTA).
* p < 0.05
§ p < 0.01
# p < 0.005.
Table 2
Redox indexes in rested (non-activated) neutrophils isolated fromWistar rats supplemented with 1 mg/kg/BW ASTA and/or FO (equivalent to 10 mg EPA/kg and 7 mg DHA/kg) for
45 days (5 day/week).
Parameter Control ASTA FO FO + ASTA
Total SOD 27.10 (±0.92) 28.26 (±1.98) 29.97 (±4.53) 32.29 (±1.44) §C
MnSOD 17.66 (±0.04) 17.85 (±2.09) 20.49 (±3.61) 21.68 (±1.16) #C
CAT 4.73 (±0.54) 3.06 (±0.54) #C 2.67 (±0.77) #C 2.69 (±0.54) #C
GPx 0.87 (±0.04) 1.67 (±0.20) #C, FO 0.43 (±0.01) #C, A, FOA 1.41 (±0.15)#C, FO
GR 0.102 (±0.014) 0.155 (±0.018) §C, #FO 0.035(±0.002) #C, A, FOA 0.139 (±0.012) *C, #FO
TBARS 3.20 (±0.37) 3.67 (±0.55) 3.65(±1.14) 2.95(±0.51)
Protein carbonyls 15.0 (±1.0) 19.9 (±1.2) *C, FO, FOA 14.0 (±0.8) *A 14.4 (±0.2) *A
GSH 3.67 (±0.32) 1.01 (±0.17) #C, F, §FOA 6.58 (±0.82) §C, #A, FOA 1.47 (±0.06) #C, FO, §A
GSSG 4.05(±0.46) 4.33 (±0.29) 1.84(±0.18) #C, A 1.32 (±0.05) #C, A
Reducing Power 0.312 (±0.045) 0.104 (±0.019) #C, FO, FOA 0.641 (±0.102) #C, A, FOA 0.358 (±0.020) #A, FO
Related to C (Control), A (ASTA), FO (Fish oil), FOA (Fish oil + ASTA).
* p < 0.05.
§ p < 0.01.
# p < 0.005.
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Fig. 2. Scores of phagocytic capacity of rat neutrophils. The assay was carried out
for 60 min, using opsonized zymosan particles. Results are expressed as mean ± -
SEM of three different experiments (n = 8 rats) performed in triplicate. §p < 0.01 or
#p < 0.005; related to C (Control).
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Fig. 3. Superoxide anion production was measured in neutrophils (5  105 per
well) under baseline and PMA-stimulated conditions. Cells were stimulated with
PMA (20 ng/well) for 30 min and superoxide anion generation was measured by
dihydroethidium (5 lM) assay. Results are expressed as mean ± SEM of three
different experiments (n = 8 rats) performed in triplicate. ⁄p < 0.05; or #p < 0.005,
related to C (Control), A (ASTA), FO (Fish oil), FOA (Fish oil + ASTA).
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FO + ASTA-fed animals showed 53%, 17%, and 65% higher O2 basal
production in neutrophils, respectively (compared to control).
Upon PMA-activation, however, a different trend was observed.
FO alone or as a component of FO + ASTA supplementation signiﬁ-
cantly reduced O2 production by approximately 10% (Fig. 3).
H2O2 production in both rested and activated neutrophils fol-
lowed the same trend as observed for O2 production, except for
PMA-activated neutrophils of ASTA-fed group, which showed 25%
lower H2O2 production than control neutrophils (Fig. 4).On the other hand, NO production (and probably other RNS that
generate nitrite as product) was apparently more affected by ASTA
supplementation than by FO per se (Fig. 5). Even though no signif-
icant difference was observed in rested neutrophils, LPS stimulus
only resulted in 45% lower NO production in neutrophils isolated
from ASTA-fed animals (either alone or combined with FO).
Concomitantly, the inﬂux of Ca2+ ions in LPS-activated neutrophils
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Fig. 4. Measurement of hydrogen peroxide production in neutrophils (5  105 per
well) under baseline and PMA-stimulated conditions. Hydrogen peroxide produc-
tion was induced with PMA (20 ng/well) for 1 h, and measured as absorbance
increase at 620 nm due to horseradish peroxidase-dependent oxidation of phenol
red. Results are expressed as mean ± SEM of three different experiments (n = 8 rats)
performed in triplicate. ⁄p < 0.05; §p < 0.01; or #p < 0.005, related to C (Control).
#signiﬁcantly different (#p < 0.005) between C + PMA group and ASTA + PMA or
FO + PMA groups.
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Fig. 5. Measurement of nitric oxide production in neutrophils (5  105 per well)
under baseline and LPS-stimulated conditions. Cells were stimulated with LPS
(10 lg/well) for 4 h and nitric oxide production was measured by Griess reagent
assay. Results are expressed as mean ± SEM of three different experiment (n = 8
rats) performed in triplicate. ⁄p < 0.05; or #p < 0.005, related to C (Control), A (ASTA),
FO (Fish oil), FOA (Fish oil + ASTA).
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Fig. 6. The progression of auto-induced lipid peroxidation after PMA-stimulation in
neutrophils monitored by C11-BODIPY ﬂuorescence decay. Cells (5  105/well) were
pre-loaded with 3.2 lM C11-BODIPY581/591 (60 min). PMA (100 ng) was added to
trigger ROS production and membrane oxidation. Results are expressed as
mean ± SEM of three different experiment (n = 8 rats) performed in triplicate.
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and/or FO, data not shown).
The progression of auto-induced lipid peroxidation after PMA-
stimulation in neutrophils was monitored by C11-BODIPY581/591
ﬂuorescence decay (Fig. 6). Based on a ﬁrst-order exponential de-
cay function (see Materials and Methods), it is clear that the plas-
ma membrane of neutrophils from all supplemented groups was
less exposed to oxidative injury than that from untreated control
animals. Taking kinetic constants into account (k1), ASTA supple-
mentation was proven to limit the progression of auto-oxidation
in neutrophil membrane after PMA-stimulus, regardless of FO
presence (Table 3). All ﬁtting exponential curves were relatively
well correlated (R2P 0.600).
4. Discussion
4.1. Plasma parameters
As observed by other authors, ASTA supplementation alone
(1 mg/kg herein) resulted in hyperlipidemia and hypercholesterol-
emia in experimental animals (Table 1) [35]. Similar effects were
also observed in rats supplemented with the marine carotenoid
canthaxanthin, the immediate precursor of ASTA in thecarotenogenesis pathway [35]. The hypercholesterolemic effect of
these xanthophylls is not related to reported mechanisms of non-
polar carotenoids in mammalians, because beta-carotene does
not induce changes in plasma cholesterol.
Higher lipid concentration in plasma of ASTA-fed rats was not
followed by hyperglycemic conditions or increased antioxidant
capacity, as demonstrated by GSH/GSSG scores and oxidative
modiﬁcations in plasma lipids (Table 1). Based on previous studies
from our group, the ASTA effect on plasma glucose, cholesterol or
triacylglycerol concentrations is supposedly dependent on the
carotenoid content in the diet, since those changes were not ob-
served when animals were fed with a 20-fold higher dose of ASTA
[12]. Interestingly, Aoi et al. (2008) showed that exercising mice
fed with 0.02% (w/w) ASTA consumed more lipids than glucose as
energy source, resulting in an increased running time to exhaustion
[36]. Although FO supplementation alone did not alter physiologi-
cal or redox parameters in plasma (compared to control), its combi-
nation with ASTA substantially augmented GSH content, its redox
turnover (conversion of oxidized GSSG back to its reduced form,
GSH) and, consequently, thiol-dependent reducing power of plasma
(Table 1). Glutathione-based and lipid peroxidation markers in
plasma conﬁrm our previous results of the biochemical and puta-
tive anxiolytic effects of the ASTA + FO treatment [37]. Important
hypolipidemic and hypocholesterolemic effects were also observed
in the ASTA + FO group (compared to ASTA-fed animals), suggesting
a speciﬁc effect of FO supplementation, since similar results were
also found in the FO-group. Accordingly, experiments in humans
indicate a profound hypolipidemic effect of FO, especially by lower-
ing plasma triacylglycerol [38]. In agreement with Engler et al. [39],
we also observed hypolipidemic/hypocholesterolemic effects asso-
ciated with 65% higher NO concentration in plasma of FO + ASTA
supplemented Wistar rats (Table 1), although supplementation
with FO alone demonstrated a non-signiﬁcant tendency for higher
values (p = 0.175). Reduction in lipidemia and cholesterolemia cou-
pled to adequate redox rebalance and higher NO bioavailability in
plasma has been currently suggested as positive events for prevent-
ing the progression of early coronary heart disease in high-risk
patients [40].
4.2. Non-activated neutrophils
The long-term FO + ASTA supplementation resulted in substan-
tial antioxidant responses in rat neutrophils, compared to control.
Both total and mitochondrial MnSOD activities were proportion-
ally increased by approximately 20%, whereas CAT showed 43%
lower activities (Table 2). Higher SOD activities in neutrophils from
Table 3
Kinetic rates of the exponential decay of C11-BODIPY ﬂuorescence induced by PMA activation in neutrophils isolated fromWistar rats supplemented with 1 mg/kg/BW ASTA and/
or FO (equivalent to 10 mg EPA/kg and 7 mg DHA/kg). First-order exponential decay: y(RFU) = y0 + A1.e(t/k1) for 45 days (5 days/week). y = Fluorescence intensity; RFU = relative
ﬂuorescence units; y0 = initial relative ﬂuorescence; A1 = intensity factor; t = time (s); k1 = rate constant.
Experimental groups y0 A1 k1 R2
Control 0.946 (±0.005) 0.828 (±0.581) 260.93 (±70.6) 0.918
ASTA 0.984 (±0.016) 3.10 (±9.33) 131.4 (±72.4)*C 0.600
FO 0.972 (±0.003) 0.839 (±0.968) 217.2 (±78.0) 0.859
FO+ASTA 0.984 (±0.002) 1.29 (±2.83) 157.4 (± 76.0)*C 0.652
* p < 0.05, related to: C (Control); A (ASTA group); FO (Fish oil group); or FOA (Fish oil + ASTA group).
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basal O2 production of neutrophils (Fig. 3). Accordingly, basal
H2O2 production – product of O

2 dismutation by SOD isoforms –
was also augmented (60%) in non-activated neutrophils of the
FO + ASTA group (Fig. 4). Thus, in order to cope with the increase
of cytotoxic H2O2 concentrations and the unresponsiveness of
CAT activity (Table 2), the GSH-dependent enzyme system, com-
prised by coupling enzymes GPx/GR, was upregulated (62% and
36%, respectively) to stabilize the reducing power of resting
FO + ASTA neutrophils (Table 2). Interestingly, neutrophils from
ASTA-fed animals also showed higher GPx/GR activities, lower
CAT activity, but unaltered SOD isoform activities: under these cir-
cumstances, the reducing power was drastically diminished by 65%
and protein oxidation was exacerbated by 33% (Table 2). Organic
peroxides, main products of lipid/membrane oxidation, and H2O2
are regular substrates for GPx in most cells. We assume that spe-
ciﬁc GSH-dependent enzymes GPx/GR – but not CAT – were upreg-
ulated as cellular responses to circumvent increased levels of
organic peroxides from exacerbated lipid peroxidation, but not
H2O2 itself. Fig. 6 corroborates this hypothesis. Similar results were
obtained by our group in an analogous study performed in lymph
nodes lymphocytes. Increased activities of total/SOD, GR and GPx
were observed in lymphocytes from rats supplemented with
FO + ASTA [41]. Singular cells in the immune system, such as neu-
trophils and lymphocytes, which exert extremely different func-
tions in the innate and adaptive immune response, respectively,
can present similar responses to supplemention with FO + ASTA.
Hattori et al. [42] reported the induction of GPx activity by H2O2
exposure in neutrophils, although a key participation of the inﬂam-
matory cytokine TNF-a was also evidenced. Furthermore, the
depletion observed in neutrophil GSH content in FO + ASTA (and
ASTA-fed) animals is consistent with speciﬁc percentage changes
of GPx and GR, which favors the consumption of reduced GSH
forms. On the other hand, proportional increases of GSSG content
were not observed (Table 2). One plausible hypothesis for that fact
is the substantial utilization of a fraction of the total GSH content
for S-glutathionylation of proteins, a reversible post-translational
modiﬁcation that provides protection of protein thiol groups from
oxidation and thus proteins from denaturation, concomitantly
serving as a redox signal transducer [43]. Reinforcing the afore-
mentioned key participation of SOD isoforms in sustaining redox
balance and functionality of neutrophils, no changes in protein oxi-
dation scores were observed in neutrophils of FO + ASTA animals,
although a signiﬁcant increase (33%) was found in neutrophils of
ASTA-fed animals. Altogether, these data depict the redox scenario
of most circulating (rested?) neutrophils from experimental groups
and, thus, are possibly related to the life-span of neutrophils under
non-inﬂammatory conditions. On the other hand, neutrophil
(short) life-span is actually more dependent on the occurrence of
inﬂammatory events, since migration, inﬁltration, and particularly
the oxidative burst during pathogen (or chemical, herein) activa-
tion expose these immune cells to harsher oxidative conditions.
Thus, it is desirable to investigate the redox balance and progres-
sion of oxidative insult in active neutrophils, exactly during theirmassive exposure to higher concentrations of self-generated ROS/
RNS. Furthermore, a crucial mechanism of cell death – apoptosis
– is tightly related to redox unbalances in active neutrophils [44].
4.3. Activated neutrophils
Fish oil supplementation itself was related to the increased
phagocytic activity of neutrophils (both FO and FO + ASTA groups),
since ASTA supplementation alone did not result in higher phago-
cytic scores (Fig. 2). Moreover, after PMA activation, neutrophils
from FO-fed groups (both FO- and FO + ASTA, but not from ASTA-
group) showed reduced O2 production, whereas all supplemented
animals had lower H2O2 generation (Figs. 3 and 4). These data sug-
gest that phagocytic activity was more closely related to changes in
O2 production of activated neutrophils and/or to pre-acquired po-
sitive redox balance during the FO- and FO-ASTA supplementation
period. Nevertheless, it is plausible to suggest that the improve-
ment of the immune function (phagocytic activity herein) was a di-
rect effect of FO supplementation in our experimental groups.
Contrasting with this result, FO + ASTA supplementation promoted
a reduced proliferative capacity of activated T- and B-lymphocytes
as showed in our previous study [41]. The consensus from histolog-
ical studies and tracking ﬂuorescent-targeted cells is that the
majority of inﬂammatory neutrophils never leave an inﬂamed site
to return to blood stream, since most activated cells die in situ due
to cellular processes closely related to oxidative stress: apoptosis
or necrosis [45]. It is well conceived that apoptosis is the preferred
injury limiting mechanism for the removal of non-functional neu-
trophils from inﬂamed sites. Moreover, it is notably related to aug-
mented rates of ROS/RNS production (by intrinsic pathway), Ca2+
inﬂux disruption, and progressive oxidative events in several im-
mune cells, including neutrophils [46]. Therefore, it is possible that
the antioxidant background in neutrophils (obtained during the
supplementation period) could affect: (i) their life-span as active
immune cells; (ii) their functionality during inﬂammatory pro-
cesses; and (iii) the mechanism by which active neutrophils are de-
graded (with consequences for remaining cells and tissue). As also
observed in lymphocytes [12], ASTA supplementation here offered
putative anti-apoptotic effects in neutrophils, based on reduced
production of NO and unaltered intracellular Ca2+ release (Fig. 5).
In addition, the powerful antioxidant activity of ASTA [14] was
here evidenced in neutrophils by the signiﬁcantly lower rate con-
stant (k1; Table 3) of the exponential progression of membrane oxi-
dation after PMA activation in neutrophils from ASTA-fed animals
(both ASTA- and FO + ASTA groups; Fig. 6). This sensitive assay by
the radical-sensitive probe C11-BODIPY depicts the slower pro-
gression of lipid oxidation in neutrophil membrane from both
ASTA- and FO + ASTA-fed animals (see Section 2). Hence, it is rea-
sonable to assume that ASTA supplementation offered extended
protection to auto-induced oxidation in neutrophils membrane,
with possible inﬂuence on cell survival and life-span.
Putative anti-apoptotic effects in rat neutrophils are here
suggested from combined FO + ASTA supplementation, since lower
O2 production was concomitantly monitored with lower NO

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compartments to produce the pro-apoptotic factor, peroxynitrite
(ONOO) [47]. Interestingly, low doses of NO were shown to pre-
vent killing of rat hepatocytes by tert-butylhydroperoxide, whereas
further increasing doses resulted in increased killing [48]. This dual
pro-/antioxidant role of NO has been also reported in several other
cell types and could represent an important redox switch for
triggering apoptosis in neutrophils.
4.4. Mechanistic aspects
A bulk of data has demonstrated that the beneﬁcial action of
dietary carotenoids on the immune system is independent of their
provitamin A or retinal-derived activities. Most of the immune
improving effects provided by nonprovitamin A carotenoids – such
as lycopene, canthaxanthin, lutein and ASTA – on humans and ani-
mals has been strongly associatedwith their antioxidant properties,
even though recent studies also addressed their role in gene regula-
tion, apoptosis and angiogenesis [49]. The pharmacodynamics of
ASTA plays an essential role in determining its plasma concentra-
tion, putative direct interaction with circulating neutrophils, and
targeting of tissues. Petri & Lundebye (2007) evaluated the tissue
distribution of ASTA after oral administration to rats for two weeks,
and found that ASTA accumulated primarily in the spleen, kidneys,
adrenals, liver, skin and eyes [50]. Tested as an anti-carcinogenic
agent, the serum concentration of ASTA was approximately
1.2 lM following a 0.02% ASTA supplementation protocol for four
weeks [51]. Nevertheless, single/multiple oral administrations of
ASTA resulted in short-term accumulation in mice liver, in contrast
to the fast elimination of unmodiﬁed ASTA from plasma [52]. ASTA
short-term concentration in mammal liver was shown to propor-
tionally inhibit the activity of hepatic NADPH P450 reductase, lead-
ing to detrimental toxicological dysfunctions [53]. Although still
obscure, the deactivation of hepatic NADPH P450 reductase could
be associated with a hypothetical additional NADPH supply for
ASTA-mediated triacylglycerol and cholesterol biosynthesis in the
liver. This hypothesis is in agreement with hyperlipidemia and
hypercholesterolemia observed in ASTA-fed rats, as shown in Table
1. The speciﬁc mechanism of NADPH P450 reductase inhibition by
ASTA is dose-dependent and related to inhibition of cytochrome c
reduction in microsomes [54]. Therefore, ASTA could directly affect
electron transfer on the microsomal membrane of hepatocytes due
to its powerful antioxidant properties [14,55]. Furthermore, ASTA
alone or combined with FO induced higher activities of the antiox-
idant enzymes GPx and GR belonging to the GSH-recycling system
that needs constant supply of NADPH from the pentose phosphate
pathway (Table 2).
Although ASTA supplementation alone did not increase GSH
content of plasma (p = 0.105; Table 1), the combined ASTA + FO
supplementation signiﬁcantly augmented its thiol-based antioxi-
dant capacity (approximately 2-fold higher), with putative protec-
tive effects on circulating neutrophils. Accordingly, both ASTA-
and ASTA + FO-fed animals showed lower rates of lipid oxidation,
as monitored by the ﬂuorescent probe C11-BODIPY581/591 (k1 in
Table 3). However, it remains to be investigated whether ASTA
and/or FO were properly absorbed by neutrophil membrane or
whether this was simply a result of plasma GSH-neutrophil mem-
brane interaction. FO treatment alone resulted in unexpected
downregulation of both GPx and GR by an unknown mechanism.
On the other hand, the total conversion of arachidonic acid through
the lipoxygenase pathway in platelets was shown to be lowered by
GSH depletion, which could be a consequence of diminished GR
activities [56]. Interestingly, GPx and GR activities in neutrophils
of ASTA + FO-fed animals were signiﬁcantly augmented (62% and
36%, respectively), whereas proper intracellular GSH and GSSG con-
tents both decreased by approximately 60% in neutrophils (Table 2).The main ASTA + FO effects on neutrophil functions might be asso-
ciated with the GSH-recycling system (with coadjutant collabora-
tion from total SOD, Table 2), which apparently prioritizes the use
of available plasma GSH content to protect neutrophil membrane.
The immune system is known to critically depend on accurate
cell–cell communication in order to mount an efﬁcient response
[57]. Consequently, it is tempting to suppose that ASTA + FO might
help to maintain ﬂuidity and integrity of neutrophil membranes by
reducing the oxidative damage during oxidative bursts, with possi-
ble positive effects on associated cell receptors, as well as redox-
sensitive transcription factors (especially NF-jB), cytokines and
prostaglandins [58]. Interestingly, ASTA + FO supplementation also
resulted in signiﬁcantly lower production of O2 and H2O2 during
the oxidative burst of neutrophils (Figs. 3 and 4, respectively). Alto-
gether, the redox rebalance in activated neutrophils resulted in
signiﬁcantly higher phagocytic activities, as shown in Fig. 2.
Regarding physicochemical properties of biological membranes, it
is worth mentioning that rigid, rod-like ASTA molecules, anchored
transversally across lipid bilayers, restrict molecular motion of lip-
ids and proteins, thus affecting membrane ﬂuidity and increasing
structural stability [59]. On the other hand, n-3/PUFA such as
DHA and EPA (present in FO) were shown to induce an opposite ef-
fect on biological membranes [60]. Based on the fact that major
ROS production during the oxidative burst of neutrophils also oc-
curs in membranes (catalyzed by NADPH oxidases), it is reasonable
to assume that the proportion of n-3/PUFA and ASTA incorporated
in neutrophil membranes could drastically affect physicochemical
properties of lipid bilayers, with crucial consequences in terms of
neutrophil function and whole immune responsiveness. Further
studies are necessary to better understand such molecular-based
– but truly relevant – aspects of ASTA and/or FO supplementation
in immune enhancement.
5. Concluding remarks
The present study strongly suggests beneﬁcial effects of
FO + ASTA supplementation for immune competence, based on
the redox balance in plasma (signiﬁcant increase in GSH-dependent
reducing power), non-activated neutrophils (increased glutathi-
one-recycling enzymes GPx and GR) and PMA-activated neutrophils
(lower O2 , H2O2, andNO
 generation, reducedmembrane oxidation,
but higher phagocytic activity) of Wistar rats. The effects of ASTA
and FO combination were summative rather than synergistic, since
FO strongly contributed to hypolipidemic/hypocholesterolemic ef-
fects on plasma plus increased phagocytic activity in activated neu-
trophils, whereas ASTA better offered antioxidant/anti-apoptotic
effects to PMA-activated neutrophils. The bulk of data reinforces
the hypothesis that habitual consumption of marine ﬁsh (e.g. sal-
mon, which is a natural source of both astaxanthin and ﬁsh oil) is
strongly associated with human health, in particular with improve-
ment of immune response, and lower risks for vascular and infec-
tious pathologies [61].
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